| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1191/1352458504ms1023oa Proteomic analysis of multiple sclerosis cerebrospinal fluidDepartment of Neurology, University of Colorado Health Sciences Center, Denver, CO 80262, USA, barbara.hammack{at}ushsc.edu
Biochemical Mass Spectrometry Facility, University of Colorado Health Sciences Center, Denver, CO 80262, USA
Biochemical Mass Spectrometry Facility, University of Colorado Health Sciences Center, Denver, CO 80262, USA
Biochemical Mass Spectrometry Facility, University of Colorado Health Sciences Center, Denver, CO 80262, USA
Department of Neurology, University of Colorado Health Sciences Center, Denver, CO 80262, USA
Department of Neurology, University of Colorado Health Sciences Center, Denver, CO 80262, USA
Department of Neurology, University of Colorado Health Sciences Center, Denver, CO 80262, USA, Department of Microbiology, University of Colorado Health Sciences Center, Denver, CO 80262, USA Two-dimensional gel electrophoresis and peptide mass fingerprinting were used to identify proteins in cerebrospinal fluid (C SF) pooled from three patients with multiple sclerosis (MS) and in C SF pooled from three patients with non-MS inflammatory central nervous system (C NS) disorders. Resolution of C SF proteins on three pH gradients (3-10, 4-7 and 6-11) enabled identification of a total of 430 spots in the MS C SF proteome that represented 61 distinct proteins. The gels containing MS C SF revealed 103 protein spots that were not seen on control gels. A ll but four of these 103 spots were proteins known to be present in normal human C SF. The four exceptio ns were: C RTAC -1B (cartilage acidic protein), tetranectin (a plasminogen-binding protein), SPARC -like protein (a calcium binding cell signalling glycoprotein), and autotaxin t (a phosphodiesterase). It remains unknown whether these four proteins are related to the cause and patho genesis of MS.
Key Words: cerebrospinal fluid multiple sclerosis proteomics
This article has been cited by other articles:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




